Evidence map›Paper›PMID 35754044›Full record

ArticleMolecular psychiatry2022

Differential vulnerability of anterior cingulate cortex cell types to diseases and drugs.

Marissa A Smail, Sapuni S Chandrasena, Xiaolu Zhang, Vineet Reddy, Craig Kelley, James P Herman, Mohamed Sherif, Robert E McCullumsmith, Rammohan Shukla

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Molecular Characterization of the Progressive Landscape of Depression.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Assessing the effects of antipsychotic medications on schizophrenia functional analysis: a postmortem proteome study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Marissa A SmailDepartment of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-9743-3771
Sapuni S ChandrasenaDepartment of Mathematics and Statistics, University of Toledo, Toledo, OH, USA.
Xiaolu ZhangDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Vineet ReddyDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Craig KelleyProgram in Biomedical Engineering, SUNY Downstate Health Science University, Brooklyn, NY, USA.ORCID http://orcid.org/0000-0001-7978-5688
James P HermanDepartment of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, USA.
Mohamed SherifDepartment of Psychiatry and Human Behavior, Carney Institute for Brain Science, Brown University, Providence, RI, USA.
Robert E McCullumsmithDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Rammohan ShuklaDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA. Rammohan.Shukla@utoledo.edu.ORCID http://orcid.org/0000-0001-5776-2506
University of Toledo · USAllen Institute for Brain Science · USNeurosciences Institute · USSUNY Downstate Health Sciences University · USUniversity of Cincinnati · USVeterans Health Administration · US

Funding

Advancing the Research Careers of Women and PEERs in Brain ScienceR25NS124530 · NINDS · BROWN UNIVERSITY · PI CARLOS D AIZENMAN, Diane Lipscombe · 2022 to 2026
$1.3M
Neurobiology of loss: role of microgliaF31MH125541 · NIMH · UNIVERSITY OF CINCINNATI · PI SMAIL, MARISSA ANN · 2021 to 2023
$102k
NIMH NIH HHS F31 MH125541NINDS NIH HHS R25 NS124530U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH107487
6 · The paper itself

Abstract

In psychiatric disorders, mismatches between disease states and therapeutic strategies are highly pronounced, largely because of unanswered questions regarding specific vulnerabilities of different cell types and therapeutic responses. Which cellular events (housekeeping or salient) are most affected? Which cell types succumb first to challenges, and which exhibit the strongest response to drugs? Are these events coordinated between cell types? How does disease and drug effect this coordination? To address these questions, we analyzed single-nucleus-RNAseq (sn-RNAseq) data from the human anterior cingulate cortex-a region involved in many psychiatric disorders. Density index, a metric for quantifying similarities and dissimilarities across functional profiles, was employed to identify common or salient functional themes across cell types. Cell-specific signatures were integrated with existing disease and drug-specific signatures to determine cell-type-specific vulnerabilities, druggabilities, and responsiveness. Clustering of functional profiles revealed cell types jointly participating in these events. SST and VIP interneurons were found to be most vulnerable, whereas pyramidal neurons were least. Overall, the disease state is superficial layer-centric, influences cell-specific salient themes, strongly impacts disinhibitory neurons, and influences astrocyte interaction with a subset of deep-layer pyramidal neurons. In absence of disease, drugs profiles largely recapitulate disease profiles, offering a possible explanation for drug side effects. However, in presence of disease, drug activities, are deep layer-centric and involve activating a distinct subset of deep-layer pyramidal neurons to circumvent the disease state's disinhibitory circuit malfunction. These findings demonstrate a novel application of sn-RNAseq data to explain drug and disease action at a systems level.

Indexed as

Gyrus CinguliInterneuronsHumansNeuronsPyramidal Cells

Identifiers

PMID35754044
PMCPMC9875728
OpenAlexW4283588221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.